title: Geranylgeranylacetone suppresses inflammatory responses and improves survival after massive hepatectomy in rats.
abstract: Overproduction of heat shock protein 70 (HSP70) in the liver protects hepatocytes under various pathologic conditions. In this study we examined the effects of a nontoxic HSP70 inducer, geranylgeranylacetone (GGA), on acute hepatic failure after 95% hepatectomy in rats. When GGA (100 mg/kg) or vehicle was intragastrically administered to rats 4 hours before 95% hepatectomy, all 25 rats pretreated with vehicle died within 60 hours after the operation, whereas 10 of 25 rats pretreated with GGA survived. During the 24-hour postoperative period, GGA significantly suppressed the release of aspartate or alanine aminotransferase and elevation of the serum interleukin-6 level, and completely inhibited an increase in the serum level of tumor necrosis factor-alpha. Histologic examinations showed that GGA prevented hemorrhagic necrosis, which was observed in vehicle-treated livers more than 12 hours after the operation. During the 24-hour postoperative period, HSP70 induction was absent in remnant livers of vehicle-treated rats. In contrast, GGA stimulated the HSP70 mRNA expression and HSP70 accumulation within 4 hours, and viable hepatocytes contained abundant HSP70 in their nuclei. Our results suggest that GGA may prevent acute liver failure after massive hepatectomy, at least in part, by enhancing HSP70 induction in the remnant liver.
authors.affiliation: First Department of Surgery, School of Medicine, The University of Tokushima, Tokushima, Japan.
authors.forename: Hironobu
authors.initials: H
authors.lastname: Oda
authors.forename: Hidenori
authors.initials: H
authors.lastname: Miyake
authors.forename: Takashi
authors.initials: T
authors.lastname: Iwata
authors.forename: Kenji
authors.initials: K
authors.lastname: Kusumoto
authors.forename: Kazuhito
authors.initials: K
authors.lastname: Rokutan
authors.forename: Seiki
authors.initials: S
authors.lastname: Tashiro
mesh_terms: D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004224:Diterpenes / Q000494:pharmacology* / Q000627:therapeutic use; D018840:HSP70 Heat-Shock Proteins / Q000378:metabolism; D006498:Hepatectomy / Q000009:adverse effects*; D022781:Hepatocytes / Q000378:metabolism; D007150:Immunohistochemistry; D015850:Interleukin-6 / Q000097:blood; D017114:Liver Failure, Acute / Q000517:prevention & control*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
chemical_list: D000897:Anti-Ulcer Agents; D004224:Diterpenes; D018840:HSP70 Heat-Shock Proteins; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; C031049:geranylgeranylacetone